Global EGFR Inhibitor Supply, Demand and Key Producers, 2023-2029

Page: 109

Published Date: 08 Jun 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global EGFR Inhibitor market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global EGFR Inhibitor production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for EGFR Inhibitor, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of EGFR Inhibitor that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global EGFR Inhibitor total production and demand, 2018-2029, (K Units)
Global EGFR Inhibitor total production value, 2018-2029, (USD Million)
Global EGFR Inhibitor production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global EGFR Inhibitor consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: EGFR Inhibitor domestic production, consumption, key domestic manufacturers and share
Global EGFR Inhibitor production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global EGFR Inhibitor production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global EGFR Inhibitor production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global EGFR Inhibitor market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Roche, Boehringer-Ingelheim, Pfizer, Mylan, Genvio Pharma, Alice, Teva Pharmaceuticals and Blueprint Medicines, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World EGFR Inhibitor market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global EGFR Inhibitor Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global EGFR Inhibitor Market, Segmentation by Type
    First Generation
    Second Generation
    Three Generations
    Four Generations

Global EGFR Inhibitor Market, Segmentation by Application
    Healthcare
    Experimental Use
    Other

Companies Profiled:
    AstraZeneca
    Roche
    Boehringer-Ingelheim
    Pfizer
    Mylan
    Genvio Pharma
    Alice
    Teva Pharmaceuticals
    Blueprint Medicines
    Biotherapeutics
    Junshi Biosciences
    Cttq
    Betta Pharmaceuticals
    Qilu Pharmaceutical

Key Questions Answered
1. How big is the global EGFR Inhibitor market?
2. What is the demand of the global EGFR Inhibitor market?
3. What is the year over year growth of the global EGFR Inhibitor market?
4. What is the production and production value of the global EGFR Inhibitor market?
5. Who are the key producers in the global EGFR Inhibitor market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 EGFR Inhibitor Introduction
    1.2 World EGFR Inhibitor Supply & Forecast
        1.2.1 World EGFR Inhibitor Production Value (2018 & 2022 & 2029)
        1.2.2 World EGFR Inhibitor Production (2018-2029)
        1.2.3 World EGFR Inhibitor Pricing Trends (2018-2029)
    1.3 World EGFR Inhibitor Production by Region (Based on Production Site)
        1.3.1 World EGFR Inhibitor Production Value by Region (2018-2029)
        1.3.2 World EGFR Inhibitor Production by Region (2018-2029)
        1.3.3 World EGFR Inhibitor Average Price by Region (2018-2029)
        1.3.4 North America EGFR Inhibitor Production (2018-2029)
        1.3.5 Europe EGFR Inhibitor Production (2018-2029)
        1.3.6 China EGFR Inhibitor Production (2018-2029)
        1.3.7 Japan EGFR Inhibitor Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 EGFR Inhibitor Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 EGFR Inhibitor Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World EGFR Inhibitor Demand (2018-2029)
    2.2 World EGFR Inhibitor Consumption by Region
        2.2.1 World EGFR Inhibitor Consumption by Region (2018-2023)
        2.2.2 World EGFR Inhibitor Consumption Forecast by Region (2024-2029)
    2.3 United States EGFR Inhibitor Consumption (2018-2029)
    2.4 China EGFR Inhibitor Consumption (2018-2029)
    2.5 Europe EGFR Inhibitor Consumption (2018-2029)
    2.6 Japan EGFR Inhibitor Consumption (2018-2029)
    2.7 South Korea EGFR Inhibitor Consumption (2018-2029)
    2.8 ASEAN EGFR Inhibitor Consumption (2018-2029)
    2.9 India EGFR Inhibitor Consumption (2018-2029)

3 World EGFR Inhibitor Manufacturers Competitive Analysis
    3.1 World EGFR Inhibitor Production Value by Manufacturer (2018-2023)
    3.2 World EGFR Inhibitor Production by Manufacturer (2018-2023)
    3.3 World EGFR Inhibitor Average Price by Manufacturer (2018-2023)
    3.4 EGFR Inhibitor Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global EGFR Inhibitor Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for EGFR Inhibitor in 2022
        3.5.3 Global Concentration Ratios (CR8) for EGFR Inhibitor in 2022
    3.6 EGFR Inhibitor Market: Overall Company Footprint Analysis
        3.6.1 EGFR Inhibitor Market: Region Footprint
        3.6.2 EGFR Inhibitor Market: Company Product Type Footprint
        3.6.3 EGFR Inhibitor Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: EGFR Inhibitor Production Value Comparison
        4.1.1 United States VS China: EGFR Inhibitor Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: EGFR Inhibitor Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: EGFR Inhibitor Production Comparison
        4.2.1 United States VS China: EGFR Inhibitor Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: EGFR Inhibitor Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: EGFR Inhibitor Consumption Comparison
        4.3.1 United States VS China: EGFR Inhibitor Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: EGFR Inhibitor Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based EGFR Inhibitor Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based EGFR Inhibitor Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers EGFR Inhibitor Production Value (2018-2023)
        4.4.3 United States Based Manufacturers EGFR Inhibitor Production (2018-2023)
    4.5 China Based EGFR Inhibitor Manufacturers and Market Share
        4.5.1 China Based EGFR Inhibitor Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers EGFR Inhibitor Production Value (2018-2023)
        4.5.3 China Based Manufacturers EGFR Inhibitor Production (2018-2023)
    4.6 Rest of World Based EGFR Inhibitor Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based EGFR Inhibitor Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers EGFR Inhibitor Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers EGFR Inhibitor Production (2018-2023)

5 Market Analysis by Type
    5.1 World EGFR Inhibitor Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 First Generation
        5.2.2 Second Generation
        5.2.3 Three Generations
        5.2.4 Four Generations
    5.3 Market Segment by Type
        5.3.1 World EGFR Inhibitor Production by Type (2018-2029)
        5.3.2 World EGFR Inhibitor Production Value by Type (2018-2029)
        5.3.3 World EGFR Inhibitor Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World EGFR Inhibitor Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Healthcare
        6.2.2 Experimental Use
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World EGFR Inhibitor Production by Application (2018-2029)
        6.3.2 World EGFR Inhibitor Production Value by Application (2018-2029)
        6.3.3 World EGFR Inhibitor Average Price by Application (2018-2029)

7 Company Profiles
    7.1 AstraZeneca
        7.1.1 AstraZeneca Details
        7.1.2 AstraZeneca Major Business
        7.1.3 AstraZeneca EGFR Inhibitor Product and Services
        7.1.4 AstraZeneca EGFR Inhibitor Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 AstraZeneca Recent Developments/Updates
        7.1.6 AstraZeneca Competitive Strengths & Weaknesses
    7.2 Roche
        7.2.1 Roche Details
        7.2.2 Roche Major Business
        7.2.3 Roche EGFR Inhibitor Product and Services
        7.2.4 Roche EGFR Inhibitor Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Roche Recent Developments/Updates
        7.2.6 Roche Competitive Strengths & Weaknesses
    7.3 Boehringer-Ingelheim
        7.3.1 Boehringer-Ingelheim Details
        7.3.2 Boehringer-Ingelheim Major Business
        7.3.3 Boehringer-Ingelheim EGFR Inhibitor Product and Services
        7.3.4 Boehringer-Ingelheim EGFR Inhibitor Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Boehringer-Ingelheim Recent Developments/Updates
        7.3.6 Boehringer-Ingelheim Competitive Strengths & Weaknesses
    7.4 Pfizer
        7.4.1 Pfizer Details
        7.4.2 Pfizer Major Business
        7.4.3 Pfizer EGFR Inhibitor Product and Services
        7.4.4 Pfizer EGFR Inhibitor Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Pfizer Recent Developments/Updates
        7.4.6 Pfizer Competitive Strengths & Weaknesses
    7.5 Mylan
        7.5.1 Mylan Details
        7.5.2 Mylan Major Business
        7.5.3 Mylan EGFR Inhibitor Product and Services
        7.5.4 Mylan EGFR Inhibitor Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Mylan Recent Developments/Updates
        7.5.6 Mylan Competitive Strengths & Weaknesses
    7.6 Genvio Pharma
        7.6.1 Genvio Pharma Details
        7.6.2 Genvio Pharma Major Business
        7.6.3 Genvio Pharma EGFR Inhibitor Product and Services
        7.6.4 Genvio Pharma EGFR Inhibitor Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Genvio Pharma Recent Developments/Updates
        7.6.6 Genvio Pharma Competitive Strengths & Weaknesses
    7.7 Alice
        7.7.1 Alice Details
        7.7.2 Alice Major Business
        7.7.3 Alice EGFR Inhibitor Product and Services
        7.7.4 Alice EGFR Inhibitor Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Alice Recent Developments/Updates
        7.7.6 Alice Competitive Strengths & Weaknesses
    7.8 Teva Pharmaceuticals
        7.8.1 Teva Pharmaceuticals Details
        7.8.2 Teva Pharmaceuticals Major Business
        7.8.3 Teva Pharmaceuticals EGFR Inhibitor Product and Services
        7.8.4 Teva Pharmaceuticals EGFR Inhibitor Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Teva Pharmaceuticals Recent Developments/Updates
        7.8.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
    7.9 Blueprint Medicines
        7.9.1 Blueprint Medicines Details
        7.9.2 Blueprint Medicines Major Business
        7.9.3 Blueprint Medicines EGFR Inhibitor Product and Services
        7.9.4 Blueprint Medicines EGFR Inhibitor Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Blueprint Medicines Recent Developments/Updates
        7.9.6 Blueprint Medicines Competitive Strengths & Weaknesses
    7.10 Biotherapeutics
        7.10.1 Biotherapeutics Details
        7.10.2 Biotherapeutics Major Business
        7.10.3 Biotherapeutics EGFR Inhibitor Product and Services
        7.10.4 Biotherapeutics EGFR Inhibitor Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Biotherapeutics Recent Developments/Updates
        7.10.6 Biotherapeutics Competitive Strengths & Weaknesses
    7.11 Junshi Biosciences
        7.11.1 Junshi Biosciences Details
        7.11.2 Junshi Biosciences Major Business
        7.11.3 Junshi Biosciences EGFR Inhibitor Product and Services
        7.11.4 Junshi Biosciences EGFR Inhibitor Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Junshi Biosciences Recent Developments/Updates
        7.11.6 Junshi Biosciences Competitive Strengths & Weaknesses
    7.12 Cttq
        7.12.1 Cttq Details
        7.12.2 Cttq Major Business
        7.12.3 Cttq EGFR Inhibitor Product and Services
        7.12.4 Cttq EGFR Inhibitor Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Cttq Recent Developments/Updates
        7.12.6 Cttq Competitive Strengths & Weaknesses
    7.13 Betta Pharmaceuticals
        7.13.1 Betta Pharmaceuticals Details
        7.13.2 Betta Pharmaceuticals Major Business
        7.13.3 Betta Pharmaceuticals EGFR Inhibitor Product and Services
        7.13.4 Betta Pharmaceuticals EGFR Inhibitor Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Betta Pharmaceuticals Recent Developments/Updates
        7.13.6 Betta Pharmaceuticals Competitive Strengths & Weaknesses
    7.14 Qilu Pharmaceutical
        7.14.1 Qilu Pharmaceutical Details
        7.14.2 Qilu Pharmaceutical Major Business
        7.14.3 Qilu Pharmaceutical EGFR Inhibitor Product and Services
        7.14.4 Qilu Pharmaceutical EGFR Inhibitor Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Qilu Pharmaceutical Recent Developments/Updates
        7.14.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 EGFR Inhibitor Industry Chain
    8.2 EGFR Inhibitor Upstream Analysis
        8.2.1 EGFR Inhibitor Core Raw Materials
        8.2.2 Main Manufacturers of EGFR Inhibitor Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 EGFR Inhibitor Production Mode
    8.6 EGFR Inhibitor Procurement Model
    8.7 EGFR Inhibitor Industry Sales Model and Sales Channels
        8.7.1 EGFR Inhibitor Sales Model
        8.7.2 EGFR Inhibitor Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World EGFR Inhibitor Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World EGFR Inhibitor Production Value by Region (2018-2023) & (USD Million)
    Table 3. World EGFR Inhibitor Production Value by Region (2024-2029) & (USD Million)
    Table 4. World EGFR Inhibitor Production Value Market Share by Region (2018-2023)
    Table 5. World EGFR Inhibitor Production Value Market Share by Region (2024-2029)
    Table 6. World EGFR Inhibitor Production by Region (2018-2023) & (K Units)
    Table 7. World EGFR Inhibitor Production by Region (2024-2029) & (K Units)
    Table 8. World EGFR Inhibitor Production Market Share by Region (2018-2023)
    Table 9. World EGFR Inhibitor Production Market Share by Region (2024-2029)
    Table 10. World EGFR Inhibitor Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World EGFR Inhibitor Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. EGFR Inhibitor Major Market Trends
    Table 13. World EGFR Inhibitor Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World EGFR Inhibitor Consumption by Region (2018-2023) & (K Units)
    Table 15. World EGFR Inhibitor Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World EGFR Inhibitor Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key EGFR Inhibitor Producers in 2022
    Table 18. World EGFR Inhibitor Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key EGFR Inhibitor Producers in 2022
    Table 20. World EGFR Inhibitor Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global EGFR Inhibitor Company Evaluation Quadrant
    Table 22. World EGFR Inhibitor Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and EGFR Inhibitor Production Site of Key Manufacturer
    Table 24. EGFR Inhibitor Market: Company Product Type Footprint
    Table 25. EGFR Inhibitor Market: Company Product Application Footprint
    Table 26. EGFR Inhibitor Competitive Factors
    Table 27. EGFR Inhibitor New Entrant and Capacity Expansion Plans
    Table 28. EGFR Inhibitor Mergers & Acquisitions Activity
    Table 29. United States VS China EGFR Inhibitor Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China EGFR Inhibitor Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China EGFR Inhibitor Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based EGFR Inhibitor Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers EGFR Inhibitor Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers EGFR Inhibitor Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers EGFR Inhibitor Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers EGFR Inhibitor Production Market Share (2018-2023)
    Table 37. China Based EGFR Inhibitor Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers EGFR Inhibitor Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers EGFR Inhibitor Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers EGFR Inhibitor Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers EGFR Inhibitor Production Market Share (2018-2023)
    Table 42. Rest of World Based EGFR Inhibitor Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers EGFR Inhibitor Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers EGFR Inhibitor Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers EGFR Inhibitor Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers EGFR Inhibitor Production Market Share (2018-2023)
    Table 47. World EGFR Inhibitor Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World EGFR Inhibitor Production by Type (2018-2023) & (K Units)
    Table 49. World EGFR Inhibitor Production by Type (2024-2029) & (K Units)
    Table 50. World EGFR Inhibitor Production Value by Type (2018-2023) & (USD Million)
    Table 51. World EGFR Inhibitor Production Value by Type (2024-2029) & (USD Million)
    Table 52. World EGFR Inhibitor Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World EGFR Inhibitor Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World EGFR Inhibitor Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World EGFR Inhibitor Production by Application (2018-2023) & (K Units)
    Table 56. World EGFR Inhibitor Production by Application (2024-2029) & (K Units)
    Table 57. World EGFR Inhibitor Production Value by Application (2018-2023) & (USD Million)
    Table 58. World EGFR Inhibitor Production Value by Application (2024-2029) & (USD Million)
    Table 59. World EGFR Inhibitor Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World EGFR Inhibitor Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 62. AstraZeneca Major Business
    Table 63. AstraZeneca EGFR Inhibitor Product and Services
    Table 64. AstraZeneca EGFR Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. AstraZeneca Recent Developments/Updates
    Table 66. AstraZeneca Competitive Strengths & Weaknesses
    Table 67. Roche Basic Information, Manufacturing Base and Competitors
    Table 68. Roche Major Business
    Table 69. Roche EGFR Inhibitor Product and Services
    Table 70. Roche EGFR Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Roche Recent Developments/Updates
    Table 72. Roche Competitive Strengths & Weaknesses
    Table 73. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 74. Boehringer-Ingelheim Major Business
    Table 75. Boehringer-Ingelheim EGFR Inhibitor Product and Services
    Table 76. Boehringer-Ingelheim EGFR Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Boehringer-Ingelheim Recent Developments/Updates
    Table 78. Boehringer-Ingelheim Competitive Strengths & Weaknesses
    Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 80. Pfizer Major Business
    Table 81. Pfizer EGFR Inhibitor Product and Services
    Table 82. Pfizer EGFR Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Pfizer Recent Developments/Updates
    Table 84. Pfizer Competitive Strengths & Weaknesses
    Table 85. Mylan Basic Information, Manufacturing Base and Competitors
    Table 86. Mylan Major Business
    Table 87. Mylan EGFR Inhibitor Product and Services
    Table 88. Mylan EGFR Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Mylan Recent Developments/Updates
    Table 90. Mylan Competitive Strengths & Weaknesses
    Table 91. Genvio Pharma Basic Information, Manufacturing Base and Competitors
    Table 92. Genvio Pharma Major Business
    Table 93. Genvio Pharma EGFR Inhibitor Product and Services
    Table 94. Genvio Pharma EGFR Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Genvio Pharma Recent Developments/Updates
    Table 96. Genvio Pharma Competitive Strengths & Weaknesses
    Table 97. Alice Basic Information, Manufacturing Base and Competitors
    Table 98. Alice Major Business
    Table 99. Alice EGFR Inhibitor Product and Services
    Table 100. Alice EGFR Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Alice Recent Developments/Updates
    Table 102. Alice Competitive Strengths & Weaknesses
    Table 103. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 104. Teva Pharmaceuticals Major Business
    Table 105. Teva Pharmaceuticals EGFR Inhibitor Product and Services
    Table 106. Teva Pharmaceuticals EGFR Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Teva Pharmaceuticals Recent Developments/Updates
    Table 108. Teva Pharmaceuticals Competitive Strengths & Weaknesses
    Table 109. Blueprint Medicines Basic Information, Manufacturing Base and Competitors
    Table 110. Blueprint Medicines Major Business
    Table 111. Blueprint Medicines EGFR Inhibitor Product and Services
    Table 112. Blueprint Medicines EGFR Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Blueprint Medicines Recent Developments/Updates
    Table 114. Blueprint Medicines Competitive Strengths & Weaknesses
    Table 115. Biotherapeutics Basic Information, Manufacturing Base and Competitors
    Table 116. Biotherapeutics Major Business
    Table 117. Biotherapeutics EGFR Inhibitor Product and Services
    Table 118. Biotherapeutics EGFR Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Biotherapeutics Recent Developments/Updates
    Table 120. Biotherapeutics Competitive Strengths & Weaknesses
    Table 121. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
    Table 122. Junshi Biosciences Major Business
    Table 123. Junshi Biosciences EGFR Inhibitor Product and Services
    Table 124. Junshi Biosciences EGFR Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Junshi Biosciences Recent Developments/Updates
    Table 126. Junshi Biosciences Competitive Strengths & Weaknesses
    Table 127. Cttq Basic Information, Manufacturing Base and Competitors
    Table 128. Cttq Major Business
    Table 129. Cttq EGFR Inhibitor Product and Services
    Table 130. Cttq EGFR Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Cttq Recent Developments/Updates
    Table 132. Cttq Competitive Strengths & Weaknesses
    Table 133. Betta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 134. Betta Pharmaceuticals Major Business
    Table 135. Betta Pharmaceuticals EGFR Inhibitor Product and Services
    Table 136. Betta Pharmaceuticals EGFR Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Betta Pharmaceuticals Recent Developments/Updates
    Table 138. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 139. Qilu Pharmaceutical Major Business
    Table 140. Qilu Pharmaceutical EGFR Inhibitor Product and Services
    Table 141. Qilu Pharmaceutical EGFR Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 142. Global Key Players of EGFR Inhibitor Upstream (Raw Materials)
    Table 143. EGFR Inhibitor Typical Customers
    Table 144. EGFR Inhibitor Typical Distributors
List of Figure
    Figure 1. EGFR Inhibitor Picture
    Figure 2. World EGFR Inhibitor Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World EGFR Inhibitor Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World EGFR Inhibitor Production (2018-2029) & (K Units)
    Figure 5. World EGFR Inhibitor Average Price (2018-2029) & (US$/Unit)
    Figure 6. World EGFR Inhibitor Production Value Market Share by Region (2018-2029)
    Figure 7. World EGFR Inhibitor Production Market Share by Region (2018-2029)
    Figure 8. North America EGFR Inhibitor Production (2018-2029) & (K Units)
    Figure 9. Europe EGFR Inhibitor Production (2018-2029) & (K Units)
    Figure 10. China EGFR Inhibitor Production (2018-2029) & (K Units)
    Figure 11. Japan EGFR Inhibitor Production (2018-2029) & (K Units)
    Figure 12. EGFR Inhibitor Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World EGFR Inhibitor Consumption (2018-2029) & (K Units)
    Figure 15. World EGFR Inhibitor Consumption Market Share by Region (2018-2029)
    Figure 16. United States EGFR Inhibitor Consumption (2018-2029) & (K Units)
    Figure 17. China EGFR Inhibitor Consumption (2018-2029) & (K Units)
    Figure 18. Europe EGFR Inhibitor Consumption (2018-2029) & (K Units)
    Figure 19. Japan EGFR Inhibitor Consumption (2018-2029) & (K Units)
    Figure 20. South Korea EGFR Inhibitor Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN EGFR Inhibitor Consumption (2018-2029) & (K Units)
    Figure 22. India EGFR Inhibitor Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of EGFR Inhibitor by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for EGFR Inhibitor Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for EGFR Inhibitor Markets in 2022
    Figure 26. United States VS China: EGFR Inhibitor Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: EGFR Inhibitor Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: EGFR Inhibitor Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers EGFR Inhibitor Production Market Share 2022
    Figure 30. China Based Manufacturers EGFR Inhibitor Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers EGFR Inhibitor Production Market Share 2022
    Figure 32. World EGFR Inhibitor Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World EGFR Inhibitor Production Value Market Share by Type in 2022
    Figure 34. First Generation
    Figure 35. Second Generation
    Figure 36. Three Generations
    Figure 37. Four Generations
    Figure 38. World EGFR Inhibitor Production Market Share by Type (2018-2029)
    Figure 39. World EGFR Inhibitor Production Value Market Share by Type (2018-2029)
    Figure 40. World EGFR Inhibitor Average Price by Type (2018-2029) & (US$/Unit)
    Figure 41. World EGFR Inhibitor Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World EGFR Inhibitor Production Value Market Share by Application in 2022
    Figure 43. Healthcare
    Figure 44. Experimental Use
    Figure 45. Other
    Figure 46. World EGFR Inhibitor Production Market Share by Application (2018-2029)
    Figure 47. World EGFR Inhibitor Production Value Market Share by Application (2018-2029)
    Figure 48. World EGFR Inhibitor Average Price by Application (2018-2029) & (US$/Unit)
    Figure 49. EGFR Inhibitor Industry Chain
    Figure 50. EGFR Inhibitor Procurement Model
    Figure 51. EGFR Inhibitor Sales Model
    Figure 52. EGFR Inhibitor Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AstraZeneca
Roche
Boehringer-Ingelheim
Pfizer
Mylan
Genvio Pharma
Alice
Teva Pharmaceuticals
Blueprint Medicines
Biotherapeutics
Junshi Biosciences
Cttq
Betta Pharmaceuticals
Qilu Pharmaceutical

Related Reports

Global EGFR Inhibitor Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global EGFR Inhibitor Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 08 Jun 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global EGFR Inhibitor market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global EGFR Inhibitor Supply, Demand and Key Producers, 2024-2030

Global EGFR Inhibitor Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Pharma & Healthcare

The global EGFR Inhibitor market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

epidermal factor receptor egfr inhibitor

Epidermal Growth Factor Receptor (EGFR) Inhibitor

EGFR Inhibitor

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>